Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory From the American Heart Association.
Mar 28, 2024DOI: 10.1161/cir.0000000000001225Journal ArticleAHA
Written by: Animesh TandonJennifer N Avari SilvaAmi B BhattColin K DrummondAllison C HillAmanda E PaluchSheradon WaitsJenny E ZablahKevin C HarrisCouncil on Lifelong Congenital Heart Disease and Heart Health in the Young (Young Hearts); Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; and Council on Cardiovascular and Stroke Nursing
Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heart disease. Wearables allow patients to access their personal data and monitor their health. Despite substantial technologic advances in recent years, issues with hardware design, data analysis, and integration into the clinical workflow prevent wearables from reaching their potential in high-risk congenital heart disease populations. This science advisory reviews the use of wearables in patients with congenital heart disease, how to improve these technologies for clinicians and patients, and ethical and regulatory considerations. Challenges related to the use of wearables are common to every clinical setting, but specific topics for consideration in congenital heart disease are highlighted.
AB
Dr. Ami Bhatt
Cardiology · Adult Congenital Heart DiseaseMassachusetts General Hospitalami
